Tiotropium (SPIRIVA™): Mechanistical considerations and clinical profile in obstructive lung disease
- 1 January 1999
- journal article
- review article
- Published by Elsevier in Life Sciences
- Vol. 64 (6-7) , 457-464
- https://doi.org/10.1016/s0024-3205(98)00588-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prolonged effect of tiotropium bromide on methacholine-induced bronchoconstriction in asthma.American Journal of Respiratory and Critical Care Medicine, 1996
- Extended Therapy With Ipratropium Is Associated With Improved Lung Function in Patients With COPDChest, 1996
- Effect of Ba 679 BR, a novel long-acting anticholinergic agent, on cholinergic neurotransmission in guinea pig and human airways.American Journal of Respiratory and Critical Care Medicine, 1994
- Ba 679 BR, A novel long-acting anticholinergic bronchodilatorLife Sciences, 1993
- Management of Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 1993
- Muscarinic receptor subtypes in airwaysLife Sciences, 1993
- A Modified Bronchoalveolar Lavage Procedure That Allows Measurement of Lung Epithelial Lining Fluid VolumeAmerican Review of Respiratory Disease, 1990
- Fluid Dynamics during Bronchoalveolar LavageAmerican Review of Respiratory Disease, 1988
- Statement on Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Disease (COPD) and AsthmaAmerican Review of Respiratory Disease, 1987
- Muscarinic receptor occupation and receptor activation in the guinea‐pig ileum by some acetamides related to oxotremorineBritish Journal of Pharmacology, 1984